All data are based on the daily closing price as of October 8, 2025
a

Asahi Kasei

3407.TSE
7.85 USD
-0.14
-1.75%

Overview

Last close
7.85 usd
Market cap
10.66B usd
52 week high
8.42 usd
52 week low
6.05 usd
Target price
9.17 usd

Valuation

P/E
12.3201
Forward P/E
N/A
Price/Sales
0.5393
Price/Book Value
0.866
Enterprise Value
15.78B usd
EV/Revenue
0.7937
EV/EBITDA
6.1843

Key financials

Revenue TTM
19.90B usd
Gross Profit TTM
6.33B usd
EBITDA TTM
2.65B usd
Earnings per Share
0.64 usd
Dividend
0.25 usd
Total assets
27.51B usd
Net debt
5.80B usd

About

Asahi Kasei Corporation engages in material, homes, healthcare businesses. The company offers Pimel photosensitive polyimide/PBO precursor, a liquid photosensitive material for buffer coating and packaging applications; Sunfort dry film photoresist to form circuit patterns on printed wiring boards; Novacure, a latent curing agent for epoxy resin with storage stability; glass fabric for printed circuit boards; plastic optical fiber; suede products under the Dinamica name; Microza UF and MF industrial membranes and systems; Aciplex membranes, process equipment, and systems for caustic soda production; Hipore, a microporous polyolefin sheet which prevents the anode and cathode from contacting one another; Celgard, a lithium-ion battery separator; Deramic, a lead acid battery separator; photopolymers and platemaking systems; and fiber products under the Bemberg, ROICA, ELTAS, Bemliese, EUTEC, Precisé, SEMIA, smash, PULSHUT, Lastan, Cubit, NanoAct, ECORISE, BioCradle, CMC-Bemliese names. It also provides cling film, bags and containers, and dishwashing liquid under the Saran Wrap, Ziploc, Cookper, Frosch names; packaging products under the OPS, Suntec, Barrialon, PVDC latex, and Saran names; pharmaceutical and food additives under the Ceolous and Celphere names; and clads and anchors under the Baclad and AR Chemical Setter names. In addition, the company is involved in the provision of remodeling services; real estate-related operations; offers unit homes and apartment buildings; autoclaved aerated concrete, foundation systems, thermal insulation, and structural systems and components products; prescription drugs in the fields of orthopedics, critical/intensive care, urology, immune system, and central nervous system; enzymes and diagnostic products; and hemodialysis, therapeutic apheresis, and autologous blood-related businesses. The company was founded in 1922 and is headquartered in Tokyo, Japan.
  • Symbol
    3407.TSE
  • Exchange
    TSE
  • Isin
    JP3111200006
  • Country
    Japan
  • Sector
    Basic Materials
  • Industry
    Chemicals
  • CEO
    Dr. Ichiro Oyama M.D.
  • Headquarter
    Tokyo
  • Web site
    https://www.asahi-kasei.com
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top